Matches in Wikidata for { <http://www.wikidata.org/entity/Q91410728> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91410728 description "article scientifique publié en 2019" @default.
- Q91410728 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91410728 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91410728 description "scientific article published on 20 November 2019" @default.
- Q91410728 description "wetenschappelijk artikel" @default.
- Q91410728 description "наукова стаття, опублікована 20 листопада 2019" @default.
- Q91410728 name "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 name "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 type Item @default.
- Q91410728 label "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 label "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 prefLabel "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 prefLabel "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 P1433 Q91410728-65A8C240-F03F-426E-A741-973ACC547F8C @default.
- Q91410728 P1476 Q91410728-771C034F-6F38-43A8-9E3C-E50B20C1E966 @default.
- Q91410728 P2093 Q91410728-01EB12DC-33CD-425A-BC5F-1C107781546F @default.
- Q91410728 P2093 Q91410728-02173955-CF06-499D-8CC3-A96987CB2239 @default.
- Q91410728 P2093 Q91410728-06D3221D-75BE-409B-8399-2416A80CB092 @default.
- Q91410728 P2093 Q91410728-40511F15-9ED7-4F89-A65D-BB07D6E96A7B @default.
- Q91410728 P2093 Q91410728-587B8175-D987-4EC6-B45A-7F6E443E02B7 @default.
- Q91410728 P2093 Q91410728-E3914777-AA83-4442-9652-DE37E380796B @default.
- Q91410728 P304 Q91410728-D8DE454A-8E01-4843-8DA9-AD2345A7CA9C @default.
- Q91410728 P31 Q91410728-2C379215-621B-4482-95B2-CF4652D5A237 @default.
- Q91410728 P356 Q91410728-C0D4F015-5B6D-451B-AB99-5A12D9ED4849 @default.
- Q91410728 P478 Q91410728-52DE8944-83B6-4083-B626-E2C15EBAB504 @default.
- Q91410728 P50 Q91410728-D1062272-63C6-41C6-A834-0ED1696CA506 @default.
- Q91410728 P577 Q91410728-4C478CED-201A-4ED2-8A45-AC24417A2594 @default.
- Q91410728 P698 Q91410728-6F195270-BEE5-4D9B-833F-0FB4C7AD59E9 @default.
- Q91410728 P356 J.IJPHARM.2019.118842 @default.
- Q91410728 P698 31759109 @default.
- Q91410728 P1433 Q6051539 @default.
- Q91410728 P1476 "P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)" @default.
- Q91410728 P2093 "Alfred H Schinkel" @default.
- Q91410728 P2093 "Maria C Lebre" @default.
- Q91410728 P2093 "Mujtaba El-Lari" @default.
- Q91410728 P2093 "Rolf Sparidans" @default.
- Q91410728 P2093 "Wenlong Li" @default.
- Q91410728 P2093 "Yaogeng Wang" @default.
- Q91410728 P304 "118842" @default.
- Q91410728 P31 Q13442814 @default.
- Q91410728 P356 "10.1016/J.IJPHARM.2019.118842" @default.
- Q91410728 P478 "573" @default.
- Q91410728 P50 Q23771643 @default.
- Q91410728 P577 "2019-11-20T00:00:00Z" @default.
- Q91410728 P698 "31759109" @default.